Table 2.

Titres of antibodies to HCV-polyprotein peptides and self-homologues in treated and untreated patients with HCV infection

		Antibody titre (OD490 ± s.d.)
Tissue origin of self-homologue	Peptide homologues	Treated	Untreated	P (treated versus untreated)
Nuclear	Histone11–30	2·11 ± 0·61	2·09 ± 0·49	0·97
	HCV-pol1479–1498	2·33 ± 0·63	2·72 ± 0·95	0·14
	Matrin722–741	2·16 ± 0·63	2·54 ± 1·01	0·16
	HCV-pol743–762	1·89 ± 0·43	1·98 ± 0·34	0·62
	Replication protein133–152	2·22 ± 0·7	2·34 ± 0·87	0·69
	HCV-pol1859–1878	2·13 ± 0·5	2·16 ± 0·36	0·87
Smooth muscle	Myosin1035–1054	1·81 ± 0·29	2·33 ± 0·48	0·001
	HCV-pol1057–1076	1·67 ± 0·21	2·11 ± 0·42	0·005
	Vimentin69–88	1·70 ± 0·27	1·95 ± 0·39	0·19
	HCV-pol146–165	2·05 ± 0·43	1·76 ± 0·22	0·11
	Smoothelin698–717	1·84 ± 0·34	1·88 ± 0·35	0·8
	HCV-pol2346–2365	1·70 ± 0·17	1·66 ± 0·19	0·52

Bold = P < 0·05.